This HTML5 document contains 120 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
n11http://dx.doi.org/10.1158/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43136780
rdf:type
wikibase:Item
schema:description
мақолаи илмӣ 2010年學術文章 artigo científico scientific article published on 9 March 2010 artículu científicu espublizáu en 2010 სამეცნიერო სტატია teaduslik artikkel vedecký článok tieteellinen artikkeli articolo scientifico επιστημονικό άρθρο vetenskaplig artikel научни чланак artikull shkencor 2010年学术文章 artykuł naukowy 2010年の論文 مقالة علمية نشرت في 9 مارس 2010 2010 թվականի մարտի 9-ին հրատարակված գիտական հոդված bilimsel makale bài báo khoa học 2010年学术文章 article scientific artigo científico wissenschaftlicher Artikel научная статья artigo científico artículo científico publicado en 2010 2010年学术文章 article científic научни чланак наукова стаття, опублікована в березні 2010 2010年學術文章 vitskapeleg artikkel บทความทางวิทยาศาสตร์ wetenschappelijk artikel articol științific article scientifique 2010 nî lūn-bûn 2010年學術文章 scienca artikolo 2010年学术文章 scientific article published on 9 March 2010 vědecký článek 2010年學術文章 naučni članak научна статия 2010年学术文章 2010年学术文章 2010년 논문 tudományos cikk מאמר מדעי videnskabelig artikel vitenskapelig artikkel scientific article published on 9 March 2010 artikulong pang-agham ৯ মার্চ ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artikel ilmiah 2010年學術文章
p:P577
wds:Q43136780-1D7388BA-20CC-409C-B7C0-8284CB8EA047
wdt:P577
2010-03-09T00:00:00Z
p:P407
wds:Q43136780-811267DB-F72A-4521-9776-E2FABB99987A
wdt:P407
wd:Q1860
p:P2093
wds:Q43136780-FE800919-3EC5-4641-B010-9D857A1A68BB wds:Q43136780-E03A3C17-62A6-4DB2-BF6A-B98BA282A342 wds:Q43136780-737516E4-1E9B-4283-9E63-DC68EC8934AD wds:Q43136780-64408FE6-1D89-4092-A0B0-79AC85A94DC9 wds:Q43136780-4400D712-1E00-4308-A60A-86C53863BA26 wds:Q43136780-1A6EC9F8-B4D4-4707-A6E2-89F4FAD9035E wds:Q43136780-BC4C6813-D54D-4666-8BD0-4006ED777727 wds:Q43136780-CA4C9687-F9A4-4BAB-BA2C-C135C089156E wds:Q43136780-B176B06F-F9B7-4DD6-8BEF-018F0CFBCAC2 wds:Q43136780-A97885D4-E6FB-46FB-BFC5-BF378630C27B wds:Q43136780-13B3C18D-4B5D-42AB-93DA-7EF260DC698B wds:Q43136780-0B1E1487-819E-4EF8-ABAF-4BF693083AD2
wdt:P2093
Frances A Shepherd Helen J Ross Jennifer Garst Nevena Damjanov Afshin Dowlati Tal Z Zaks James R Rigas Joseph Aisner Habib Hassani Lance Leopold Kimberly E Allen Michael Smylie
rdfs:label
Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer
skos:prefLabel
Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer
schema:name
Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer
p:P50
wds:Q43136780-14A6DC8D-5716-4315-B9AE-39C319E93E37
wdt:P50
wd:Q94702986
p:P1476
wds:Q43136780-A398086E-2957-4FD9-8868-7971B6518F8A
wdt:P1476
Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer
p:P304
wds:Q43136780-E5483BA2-8B93-4350-948D-9A730D3AC7F8
wdt:P304
1938-1949
p:P31
wds:Q43136780-6BC7DDEC-C36F-49F4-AF2F-2EDBF9E090D7
wdt:P31
wd:Q13442814
p:P921
wds:Q43136780-E3463DAB-BAB6-43CA-9FE1-B0190AA4EBF4 wds:Q43136780-15C37AFE-AD2F-402F-9768-7C6AAFCD30EA
wdt:P921
wd:Q42824440 wd:Q6934595
p:P698
wds:Q43136780-CD958314-50FB-45A6-B51B-42D90B1AB5C5
wdtn:P698
n12:20215545
wdt:P698
20215545
p:P1433
wds:Q43136780-4916998A-C776-4CA6-9D18-2DB041550122
wdt:P1433
wd:Q332253
p:P433
wds:Q43136780-984A9C16-33DA-470A-AAA9-6151BE96A657
p:P478
wds:Q43136780-66C0E813-A5D6-4761-A962-9E71E00B1C66
wdt:P433
6
wdt:P478
16
p:P356
wds:Q43136780-AAF980EB-986E-44E3-A569-92ED3D347922
wdtn:P356
n11:1078-0432.CCR-08-3328
wdt:P356
10.1158/1078-0432.CCR-08-3328
p:P8608
wds:Q43136780-13BBF90D-BFBA-4E02-A8FC-C540CCF51897
wdt:P8608
release_bru3uzixn5bjtd3guqu5iegc5i